A detailed history of North Star Asset Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, North Star Asset Management Inc holds 7,154 shares of BMY stock, worth $402,770. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,154
Previous 7,796 8.23%
Holding current value
$402,770
Previous $323,000 14.55%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $25,461 - $33,223
-642 Reduced 8.23%
7,154 $370,000
Q2 2024

Aug 05, 2024

SELL
$40.25 - $52.99 $54,297 - $71,483
-1,349 Reduced 14.75%
7,796 $323,000
Q1 2024

May 08, 2024

BUY
$47.98 - $54.4 $116,783 - $132,409
2,434 Added 36.27%
9,145 $495,000
Q4 2023

Feb 01, 2024

SELL
$48.48 - $57.85 $168,855 - $201,491
-3,483 Reduced 34.17%
6,711 $344,000
Q3 2023

Oct 26, 2023

SELL
$57.89 - $64.73 $17,193 - $19,224
-297 Reduced 2.83%
10,194 $591,000
Q1 2023

May 10, 2023

SELL
$65.71 - $74.53 $13,141 - $14,906
-200 Reduced 1.87%
10,491 $727,000
Q4 2022

Mar 06, 2023

SELL
$68.48 - $81.09 $63,960 - $75,738
-934 Reduced 8.03%
10,691 $769,000
Q3 2022

Nov 08, 2022

SELL
$0.13 - $76.84 $53 - $31,658
-412 Reduced 3.42%
11,625 $826,000
Q2 2022

Jul 28, 2022

BUY
$72.62 - $79.98 $44,080 - $48,547
607 Added 5.31%
12,037 $927,000
Q1 2022

Apr 29, 2022

SELL
$61.48 - $73.72 $1,967 - $2,359
-32 Reduced 0.28%
11,430 $835,000
Q4 2021

Feb 07, 2022

BUY
$53.63 - $62.52 $52,289 - $60,957
975 Added 9.3%
11,462 $715,000
Q3 2021

Oct 20, 2021

BUY
$59.17 - $69.31 $100,589 - $117,827
1,700 Added 19.35%
10,487 $621,000
Q2 2021

Jul 30, 2021

SELL
$61.91 - $67.42 $2,166 - $2,359
-35 Reduced 0.4%
8,787 $587,000
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $57,740 - $65,430
1,000 Added 12.78%
8,822 $547,000
Q3 2020

Nov 02, 2020

BUY
$57.43 - $63.64 $2,297 - $2,545
40 Added 0.51%
7,822 $472,000
Q2 2020

Jul 28, 2020

SELL
$54.82 - $64.09 $4,659 - $5,447
-85 Reduced 1.08%
7,782 $458,000
Q1 2020

Apr 24, 2020

SELL
$46.4 - $67.43 $316,216 - $459,535
-6,815 Reduced 46.42%
7,867 $439,000
Q4 2019

Feb 06, 2020

BUY
$49.21 - $64.19 $147,236 - $192,056
2,992 Added 25.59%
14,682 $942,000
Q3 2019

Oct 25, 2019

SELL
$42.77 - $50.71 $10,692 - $12,677
-250 Reduced 2.09%
11,690 $593,000
Q2 2019

Aug 12, 2019

BUY
$44.62 - $49.34 $40,514 - $44,800
908 Added 8.23%
11,940 $541,000
Q1 2019

Apr 26, 2019

SELL
$45.12 - $53.8 $64,295 - $76,665
-1,425 Reduced 11.44%
11,032 $526,000
Q4 2018

Jan 29, 2019

SELL
$48.76 - $63.23 $60,950 - $79,037
-1,250 Reduced 9.12%
12,457 $648,000
Q3 2018

Oct 29, 2018

SELL
$55.19 - $62.25 $4,415 - $4,980
-80 Reduced 0.58%
13,707 $851,000
Q2 2018

Aug 10, 2018

SELL
$50.53 - $62.98 $8,842 - $11,021
-175 Reduced 1.25%
13,787 $763,000
Q1 2018

Apr 27, 2018

SELL
$59.92 - $68.98 $38,348 - $44,147
-640 Reduced 4.38%
13,962 $883,000
Q4 2017

Feb 01, 2018

BUY
$59.94 - $65.35 $56,943 - $62,082
950 Added 6.96%
14,602 $895,000
Q3 2017

Oct 25, 2017

SELL
$55.23 - $63.74 $6,020 - $6,947
-109 Reduced 0.79%
13,652 $870,000
Q3 2017

Oct 25, 2017

SELL
$55.23 - $63.74 $1,435 - $1,657
-26 Reduced 0.19%
13,761 $748,000
Q2 2017

Aug 16, 2017

BUY
N/A
13,787
13,787 $768,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track North Star Asset Management Inc Portfolio

Follow North Star Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on North Star Asset Management Inc with notifications on news.